OSE Immunotherapeuti...
ENXTPA:OSE
3,29
€0,00 (0,00%)
3,29
€0,00 (0,00%)
End-of-day quote: 04/03/2026

OSE Immunotherapeutics Stock Value

The current analyst recommendation for ENXTPA:OSE is: Buy.
Buy
Buy

OSE Immunotherapeutics Company Info

EPS Growth 5Y
46,61%
Market Cap
€0,07 B
Long-Term Debt
€0,04 B
Quarterly earnings
06/26/2026 (E)
Dividend
€0,00
Dividend Yield
0,00%
Founded
2012
Industry
Country
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

€13,00
295.14%
295.14
Last Update: 04/03/2026
Analysts: 3

Highest Price Target €21,00

Average Price Target €13,00

Lowest Price Target €8,20

In the last five quarters, OSE Immunotherapeutics’s Price Target has risen from €14,75 to €15,37 - a 4,20% increase. Two analysts predict that OSE Immunotherapeutics’s share price will increase in the coming year, reaching €13,00. This would represent an increase of 295,14%.

Top growth stocks in the health care sector (5Y.)

×